Is Capricor Therapeutics, Inc. (CAPR) a Buy, Sell, or Hold?
Capricor Therapeutics, Inc.
NASDAQ:CAPR
$20.68 USD
$0.07 (0.34%)
- Volume
- 1.09M
- Average Volume
- 1.2M
- Market Capitalization
- $945.43M
- P/E Ratio
- -8.91
- Dividend Yield
- 0.00%
- Price Target
- $50.00
- Year High
- $40.37
- Year Low
- $4.30
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $8.42
Analyst Rating
Sell
2 Rating Score
UPSIDE/DOWNSIDE
-58.6% DOWNSIDE
$50.00 Price Target
UPSIDE/DOWNSIDE HIGH
-66.6% DOWNSIDE
$62.00 Price Target High
UPSIDE/DOWNSIDE LOW
-45.6% DOWNSIDE
$38.00 Price Target Low
INSIDER TRADING
Shares
$- Last Quarter
| Analyst Company | Analyst Name | Price Target | Price When Posted | Date | Upside/Downside |
|---|---|---|---|---|---|
| Roth Capital | Boobalan Pachaiyappan | $38 | $29.81 | 2026-05-14 10:51 PM | 27.5% |
| Cantor Fitzgerald | Kristen Kluska | $62 | $33.42 | 2026-03-13 07:30 AM | 85.5% |
| Roth Capital | Boobalan Pachaiyappan | $13 | $6.2 | 2025-11-11 02:29 PM | 109.7% |
| Piper Sandler | Edward Tenthoff | $20 | $7.66 | 2025-07-11 11:32 AM | 161.1% |